1800 202 8726
Biopsy cost & quality

Does a Cheaper Biopsy — Mean a Worse Result?

A lower price does not mean a less accurate diagnosis. The quality of the pathologist reading your slide matters more than the cost of collecting it. Here is how to tell a good lab from a cheap-but-risky one.

Medically reviewed by Dr. Muralidhar Muddusetty, Surgical Oncologist, MBBS (AIIMS) · MS Surgery (AIIMS) · DNB Surg Onc · MRCS (Edinburgh) · Last reviewed September 2026

  • Price is not the quality signal — A low quote can come from an excellent NABL-accredited lab or from one that sends slides to an overloaded general pathologist.
  • The pathologist matters most — Who reads the slide determines whether a cancer subtype is correctly identified — not the needle used to collect the tissue.
  • Some add-ons cost more than the biopsy — IHC panels and molecular tests are often a multiple of the collection fee and are frequently not included in the initial quote.
  • You can get a second opinion on slides — Sending glass slides to another pathologist costs far less than a repeat biopsy and can catch a misread without any new procedure.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get an indicative cost estimate

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

A cheaper biopsy does not automatically mean a less reliable result. What determines accuracy is the pathologist reading the slide and whether the laboratory holds NABL accreditation. Some low-cost biopsies are done at excellent labs. Some expensive ones go to weaker ones. Price is not the quality signal — accreditation is.

How much does a biopsy actually cost — and what is included?

ComponentWhat it coversIndicative range, Telangana / AP (2025)
FNAC (fine needle aspiration cytology)Cytology reading, needle, basic report. Gives cell type only — not always enough for treatment planning.₹400 – ₹1,500
Core needle biopsyTissue core, H&E staining, pathology report. Usually sufficient for diagnosis and subtype classification.₹1,500 – ₹5,000
Surgical / excisional biopsyOperating theatre, anaesthesia, specimen processing. Used when a larger or intact sample is needed.₹8,000 – ₹30,000
Immunohistochemistry (IHC) panelMarker testing to confirm cancer subtype and guide treatment. Often not included in the biopsy quote.₹3,000 – ₹15,000
Molecular / genomic testingGene mutations and treatment-guiding markers. Done at specialist labs, usually invoiced separately.₹15,000 – ₹80,000

What are you actually paying for when the biopsy price goes up?

The collection procedure — the needle pass or the surgical cut — is a small part of the total cost. What you pay most for is what happens to the tissue afterwards.

A higher-priced biopsy at a reputable centre often means the specimen is processed in-house by a subspecialty onco-pathologist, with faster turnaround, better tissue preservation, and IHC done on validated equipment. A lower price sometimes reflects exactly the same quality, especially at an NABL-accredited government or teaching hospital. But it can also mean slides are sent to an external lab where they join a large backlog.

The critical variable is who reads your slides and what laboratory they work in — not the brand name above the door where the needle went in.

How do you check whether a lab is good before you book?

  1. Ask whether the lab is NABL-accredited

    NABL — the National Accreditation Board for Testing and Calibration Laboratories — is the Indian quality standard for pathology. Accredited labs pass regular external audits on equipment, reagents, staff qualifications, and reporting. A good lab will not hesitate to confirm this.

  2. Ask who reads the oncology specimens

    You want a pathologist with subspecialty training or dedicated oncology experience. Ask whether the lab has a dedicated onco-pathologist or sends slides to a general reporting pool shared across all specimen types.

  3. Ask whether IHC is done in-house or sent out

    If immunohistochemistry is referred to a third lab, it adds days to your turnaround and an extra invoice. Ask upfront so the full cost and timeline are clear before you agree to the procedure.

  4. Ask how long the report takes

    A reliable lab gives you a firm timeline. Turnaround for a core needle biopsy report is typically a few working days. Unexplained delays beyond that are worth questioning directly.

  5. Ask whether the tissue block will be stored

    The paraffin block is yours. A good lab stores it for years and can release it if you need future molecular testing or a second opinion. Confirm this before the procedure — retrieving a block from a lab that has not stored it is not possible.

What will this actually cost you?

Costs depend on the regimen, the number of cycles and your scheme eligibility. Send your reports and we will give you an itemised, indicative estimate.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Know the cost before you commit

An itemised estimate, plus a check of which schemes you may qualify for.

Book Free Consultation Call 1800 202 8726

What should I ask before agreeing to a biopsy price?

  • Is the lab NABL-accredited?
  • Does the quote include immunohistochemistry, or only tissue collection?
  • Is there a dedicated onco-pathologist reading these slides?
  • Will the paraffin block be stored, and can it be released for a second opinion?
  • Is molecular testing quoted separately, and is it needed for your case?
  • How many working days will the written report take?

What happens if the lab gets the diagnosis wrong?

A biopsy report is the foundation of your entire treatment plan. A missed subtype — for example, confusing one breast cancer subtype for another — can mean a treatment that works less well, or one that does not address the actual disease.

The risk is not usually catastrophic error. It is more often a report that is technically correct at a basic level but does not provide the detail your oncologist needs to make the right treatment choice.

If you have any doubt about your report, ask your oncologist to arrange a glass-slide review at a second laboratory. This does not mean repeating the biopsy. The same slides are sent to a different pathologist — it costs a fraction of a new procedure and carries none of the physical risk.

Always ask for the paraffin block to be stored. If new tests become relevant later, or if your disease behaves unexpectedly, having the original tissue avoids a repeat procedure entirely.

Did you know?

Cancer pathology misclassification — where a tumour subtype is missed or incompletely reported — is a documented cause of patients receiving treatment that does not match their actual tumour biology.

ESMO and ASCO both recommend subspecialty pathology review for complex or uncertain cases before treatment begins. A glass-slide second opinion costs a fraction of a repeat biopsy and carries none of the procedural risk.

Source: ESMO and ASCO guidance on subspecialty pathology consultation in oncology

Explore 71 more Understanding Your Biopsy and Whether You Need One topics

HUB — Does a Biopsy Spread Cancer? Myths and Evidence

HUB — What Is a Biopsy? Everything You Need to Know

All Understanding Your Biopsy and Whether You Need One →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Is FNAC as reliable as a core needle biopsy for cancer diagnosis?

For most cancers, no. FNAC collects individual cells and gives a cytology reading — it can tell you cancer cells are present but often cannot confirm the subtype, grade, or receptor status that determines your treatment. A core needle biopsy takes a small tissue cylinder that preserves the structure of the tumour, which is what the pathologist needs to classify the cancer precisely. Some situations — confirming a known cancer has spread to a lymph node — are well served by FNAC. But for an initial diagnosis where treatment decisions follow, your oncologist will usually ask for a core or surgical biopsy.

Can we send the slides to a better lab after getting a cheaper biopsy?

Yes, and this is a standard, recognised option. Ask the original lab to release the glass slides and the paraffin block — most accredited labs will do this on request, sometimes with a small administrative charge. The second laboratory reviews the same tissue rather than requiring new samples. The cost is far lower than a repeat biopsy, and there is no physical procedure involved. If the second report differs significantly from the first, take both reports to your oncologist and ask for an explanation of the difference before any treatment begins.

What is NABL accreditation and does it really matter for a biopsy?

NABL is the body that audits and certifies pathology labs in India against established quality standards. Accreditation means the lab has been externally reviewed for equipment calibration, reagent quality, staff qualifications, and reporting protocols. It does not guarantee a perfect result on every slide, but it does mean the basic infrastructure and processes have been independently verified. An unaccredited lab may be competent, but it has not submitted to that external check. For cancer diagnosis, where the report determines your treatment, accreditation is a reasonable minimum to ask for.

Should we always get a second pathology opinion on a cancer biopsy?

Not always, but more often than most people do. A second opinion is especially worth considering when the diagnosis is unusual, when the first report does not fully specify the subtype or receptor status, when your oncologist seems uncertain about the classification, or when treatment is aggressive or irreversible. It is also worth requesting if the biopsy was done at a small centre without a dedicated onco-pathologist. Many major cancer centres offer slide review as a routine service. Ask your oncologist whether it would be helpful in your specific case.

Does molecular testing always need to be done, or can we skip it to save money?

It depends entirely on your cancer type and what treatment is being considered. For some cancers — particularly lung, breast, colorectal, and some lymphomas — specific molecular markers directly determine which treatment will and will not work. Skipping the test in those cases is not a cost saving; it is a diagnostic gap that leads to treatment decisions based on incomplete information. For other cancers or situations, the relevant markers may already be clear from the histology alone. Ask your oncologist which tests are clinically required for your specific case and why, rather than declining all additional testing to reduce the bill.

The report just says 'malignant' — is that enough to start treatment?

Usually not. A report that says only 'malignant cells present' without a confirmed subtype, grade, or receptor status is incomplete for most treatment decisions. Your oncologist needs to know which kind of cancer it is, not just that cancer is present. If your report does not include those details, ask the pathologist's office whether IHC or further testing is required to complete the assessment. Starting treatment on an incomplete report is a risk — the treatment chosen for one subtype may be wrong for another, even within the same organ site.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation